Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lovelace Biomedical Research Institute (LBRI) operates a broad multi-therapeutic preclinical pipeline, providing IND-enabling studies, pharmacology, toxicology, and in vivo modeling for government, academic, and industry clients. It does not market its own therapies; rather, its nonclinical/clinical research and CRO services feed partner and sponsor pipelines, with documented expertise advancing programs to IND and clinical trial readiness[1][3][7][15].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Lovelace Biomedical Research Institute.